Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandon, additionalVeraTag, adjudication, Akt, Allan, andHERmark, andSelzentry, assessedHERmark, auction, Avastin, barred, begun, bevacizumab, binding, budget, budgetary, byHERmark, CEO, christine, chromogenic, CISH, clarify, climate, cognizable, cohort, Combivir, commercializeHERmark, comparison, concurrently, construct, contrast, corroborated, delisted, Delisting, discordance, downstream, downturn, driven, efavirenz, endpoint, equivocal, evaluateHERmark, excessively, expenditure, frequently, FSP, fundamental, futureVeraTag, Genentech, hereto, Hershey, heterodimer, hierarchy, homodimerization, inaccuracy, includingHERmark, indicatesHERmark, instability, invicriviroc, jointly, Kaiser, Lipton, load, log, marker, Mayo, metastasized, neck, orderingHERmark, ordinary, ourHERmarkBreast, paclitaxel, Permanente, PhenoSenseGT, pleaded, predefined, prime, proceeding, Professor, properly, proteolytically, pure, radical, reinvest, reinvested, retroactively, RNA, Robust, SABC, salary, shown, suspended, Sustiva, thatSelzentry, theSelzentry, trastuzumab, tropic, truncated, UK, Underwriter, undetectable, undistributed, University, unresolved, unstable, unsuccessful, upcoming, upper, version, week, WhileHERmark, white, withHERmark, withholding, worse, zone
Removed:
accelerating, accrue, acted, Aetna, affiliated, aide, aim, amounting, analyze, assembly, attacked, attempt, background, backlog, baruch, begin, Blue, bore, broadening, complaint, compound, comprising, continuum, discipline, display, emphasized, encountered, endorsed, enzyme, Epidermal, eTag, expiring, feel, finance, Florida, GlaxoSmithKline, HAART, hearing, hire, hired, Humana, importance, incorporate, installed, investigation, Jersey, Johnson, lacking, launch, led, maturation, mechanism, monitor, mutational, online, outlining, positioned, predictive, Prioritize, productivity, professional, profile, promising, proportion, prove, recruitment, recurrence, reflecting, relocated, relying, request, restricted, revaluation, reviewing, rule, run, separation, Shield, smaller, Specialty, speed, sustain, unconditional, variable, warrant
Filing tables
Filing exhibits
- 10-K Annual report
- 10.4 Second Amended and Restated Employment Agreement
- 10.8 Form of Executive Severance Benefits Agreement
- 10.39 Summary of Non-employee Director Compensation
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
Related press release
Monogram Biosciences similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-43114, 333-89082, 333-121437, 333-137351, and 333-149653) and on Form S-3 (Nos. 333-65716, 333-70562, 333-86892, 333-102273, 333-102995, 333-103980, 333-121438, 333-121475, 333-135096, 333-137350 and 333-141193) of Monogram Biosciences, Inc. of our report dated February 12, 2009 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 12, 2009